Repligen, BioLife received US antitrust approval Sept. 3
MLex Summary: Repligen and BioLife Solutions saw the Hart-Scott-Rodino Act waiting period for their merger expire Sept. 3, according to a securities filing. The companies filed premerger notifications on Aug. 4...To view the full article, register now.
Already a subscriber? Click here to view full article